Rabbit Polyclonal UPP2 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human Uridine phosphorylase 2 aa 1-250.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 79.99% PBS, 20% Glycerol (glycerin, glycerine)
WB | |
---|---|
Human | Tested |
Cow | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow | Dilution info - | Notes - |
Catalyzes the reversible phosphorylytic cleavage of uridine to uracil and ribose-1-phosphate which can then be utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis (PubMed:12849978, PubMed:21855639). Shows broad substrate specificity and can also accept deoxyuridine and other analogous compounds (PubMed:12849978).
Uridine phosphorylase 2, UPase 2, UrdPase 2, UPP2
Rabbit Polyclonal UPP2 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human Uridine phosphorylase 2 aa 1-250.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 79.99% PBS, 20% Glycerol (glycerin, glycerine)
The UPP2 protein also known as Uridine Phosphorylase 2 catalyzes the reversible phosphorolysis of uridine to uracil and ribose 1-phosphate. It plays a pivotal role in nucleotide metabolism. The molecular mass of UPP2 is approximately 34 kDa. The protein expresses mainly in the liver and kidney where nucleoside metabolism is highly active indicating its significant involvement in regulating nucleoside homeostasis.
This enzyme contributes to the salvage pathways of pyrimidine metabolism ensuring efficient recycling of nucleotides. It does not function alone; rather UPP2 can interact with other enzymes involved in nucleotide and nucleoside interconversions. It participates indirectly in pathways that manage nucleic acid degradation and synthesis essential for balancing cellular nucleotide pools.
UPP2 plays a role in pyrimidine salvage and catabolic pathways. It involves itself in the conversion processes within these pathways influencing DNA and RNA turnover. The protein aligns closely with enzymes such as uridine phosphorylase 1 (UPP1) which also partake in similar reactions emphasizing their cooperation in maintaining nucleotide balance.
Abnormalities in UPP2 function have implications in cancer and metabolic disorders. Altered expression or activity of UPP2 links to cancerous proliferation through its effect on nucleotide availability. Additionally disruptions in uridine metabolism could relate to certain metabolic syndromes. The interaction between UPP2 and uridine phosphorylase 1 further demonstrates their joint involvement in these conditions highlighting potential targets for therapeutic interventions.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
10% SDS PAGE
All lanes: Western blot - Anti-UPP2 antibody (ab153861) at 1/3000 dilution
Lane 1: 293T whole cell lysate at 30 µg
Lane 2: A431 whole cell lysate at 30 µg
Lane 3: HeLa whole cell lysate at 30 µg
Predicted band size: 36 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com